CPTAC Renews Funding for Proteogenomics Research at Baylor College of Medicine
June 29, 2022
June 29, 2022
HOUSTON, Texas, June 29 (TNSres) -- The Baylor College of Medicine issued the following news:
The Office of Cancer Clinical Proteomics Research at the National Cancer Institute (NCI), part of the National Institutes of Health, has reaffirmed its commitment to furthering proteogenomics research by announcing the next round of Clinical Proteomic Tumor Analysis Consortium (CPTAC) centers. As part of this new phase, Baylor College of Medicine will continue to serve as a Proteogenomic Da . . .
The Office of Cancer Clinical Proteomics Research at the National Cancer Institute (NCI), part of the National Institutes of Health, has reaffirmed its commitment to furthering proteogenomics research by announcing the next round of Clinical Proteomic Tumor Analysis Consortium (CPTAC) centers. As part of this new phase, Baylor College of Medicine will continue to serve as a Proteogenomic Da . . .